Medical Angiography Equipment - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Medical Angiography Equipment by Application (Hospital, Imaging Center, Research Institute, Others), by Types (X-Ray Angiography, CT Angiography, MR Angiography, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Medical Angiography Equipment Market Size | CAGR 7.2 Forecast 2033

Medical Angiography Equipment - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Angiography Equipment Market Overview

Medical angiography equipment comprises imaging systems—such as digital subtraction angiography (DSA), computed tomography angiography (CTA) and magnetic resonance angiography (MRA)—used to visualize blood vessels for diagnostic and interventional procedures. The Medical Angiography Equipment market size is projected to reach approximately $5.2 billion in 2025, with a growth outlook driven by a CAGR of 6% for the market forecast period 2026‑2033, underpinning a sustained industry expansion across cardiovascular and neuro‑vascular segments.

Loading chart…

Key macro drivers include the rising prevalence of cardiovascular and neuro‑vascular diseases, expanding minimally invasive intervention volumes, and rapid adoption of AI‑enabled 3‑D imaging that shortens procedure times. The industry is shaped by three dominant forces: (1) a technology shift toward digital, high‑resolution platforms; (2) evolving reimbursement and regulatory frameworks that favor evidence‑based imaging; and (3) intensifying competitive dynamics among OEMs such as Siemens Healthineers, GE Healthcare, and Philips, spurring innovation and price pressure. North America remains the largest market owing to advanced healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding hospital networks and rising per‑capita healthcare spending.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Siemens; Shimadzu; Terumo Corporation; Philips; Boston Scientific; Abbott Laboratories; Medtronic; Cardinal Health; Canon Medical Systems; AngioDynamics; B. Braun; Merit Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Angiography Equipment market is being reshaped by advances in imaging technology, shifting reimbursement landscapes, and evolving clinical protocols. Understanding the forces that drive growth, impose limits, create opportunities, and pose challenges is essential for executives steering strategic initiatives and forecasting the market size and growth forecast through 2032.

Growth Drivers2 items

Widespread adoption of high‑resolution flat‑panel detectors and AI‑enhanced image processing is reducing procedure times and radiation exposure, prompting hospitals to upgrade legacy systems and expanding the Medical Angiography Equipment market size.

Increasing prevalence of cardiovascular diseases in aging populations, combined with government‑backed screening programs, is boosting procedural volumes and fueling a robust growth forecast for angiography solutions across emerging and mature markets.

Restraints2 items

Stringent regulatory approval timelines in key regions, especially the EU Medical Device Regulation, elevate development costs and delay product launches, tempering short‑term market expansion.

Price sensitivity in publicly funded hospitals, driven by constrained healthcare budgets, pressures manufacturers to offer cost‑effective bundles, limiting premium pricing strategies for advanced systems.

Opportunities2 items

Integration of cloud‑based data analytics and tele‑radiology platforms creates recurring revenue streams and opens cross‑selling avenues for service contracts, amplifying the Medical Angiography Equipment market size.

Strategic partnerships with interventional cardiology innovators enable co‑development of hybrid devices, positioning vendors to capture a larger share of the projected growth forecast in minimally invasive therapies.

Challenges2 items

Supply‑chain disruptions for high‑purity silicon wafers and specialized contrast agents increase lead times, compelling manufacturers to reassess inventory strategies and potentially erode margins.

Intensifying competition from low‑cost Asian manufacturers pressures incumbents to accelerate innovation cycles while maintaining compliance, creating a delicate balance between speed-to-market and quality assurance.

Market Segmentation

Loading chart…

Application segmentation of the Medical Angiography Equipment market distinguishes three principal use‑cases: diagnostic, interventional, and research. Diagnostic angiography, which includes routine vascular imaging for disease detection, accounts for roughly 45 % of total revenue, driven by expanding cardiovascular screening programs and aging populations. Interventional applications—such as percutaneous coronary interventions, embolization, and endovascular repairs—represent about 40 % of the market, reflecting rising procedural volumes and the shift toward minimally invasive therapies. The remaining 15 % is attributed to research and development activities, encompassing pre‑clinical studies, device testing, and academic investigations that require high‑resolution imaging platforms. Each application contributes uniquely to the overall market size, with diagnostic and interventional segments providing the bulk of sales while research sustains innovation pipelines. This Medical Angiography Equipment segmentation framework enables analysts to assess growth dynamics and allocate resources according to demand drivers across clinical and experimental settings.

Types of Medical Angiography Equipment are categorized by imaging technology: Digital Subtraction Angiography (DSA), Computed Tomography Angiography (CTA), Magnetic Resonance Angiography (MRA), and Fluoroscopy‑based systems. DSA, the most established modality, dominates the market due to its high spatial resolution and real‑time visualization, contributing the largest share of equipment sales. CTA leverages CT scanners to produce three‑dimensional vascular reconstructions, gaining traction in hospitals that prioritize rapid, non‑invasive diagnostics, thus expanding its market proportion. MRA offers radiation‑free imaging, appealing to institutions focused on pediatric and repeat‑scan environments, and is growing steadily despite higher acquisition costs. Fluoroscopy‑based angiography remains essential for intra‑operative guidance, especially in hybrid operating rooms, sustaining a steady demand. By delineating these technology‑based types, the market taxonomy clarifies how each contributes to overall equipment adoption, informs capital‑expenditure decisions, and highlights avenues for future innovation.

Medical Angiography Equipment Segmentation Breakdown10 items

Application

Hospital

Imaging Center

Research Institute

Others

Types

X-Ray Angiography

CT Angiography

MR Angiography

Others

Regional Insights

Loading chart…

The Medical Angiography Equipment market growth remains anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Strong reimbursement frameworks and mature hospital networks drive North America’s dominance, whereas expanding middle‑class populations and government imaging initiatives accelerate Asia Pacific’s trajectory.

In North America, three key drivers shape demand: (1) robust reimbursement policies that lower acquisition barriers, (2) high adoption rates of advanced digital angiography suites in tertiary centers, and (3) sustained private‑equity investment in imaging infrastructure, reinforcing ecosystem maturity.

Europe’s market is propelled by: (1) EU‑wide health‑technology assessment harmonization encouraging cross‑border procurement, (2) aging demographics that increase cardiovascular procedure volumes, and (3) government incentives for upgrading legacy cath labs, which together sustain steady growth.

The Asia Pacific surge is underpinned by: (1) rapid urbanization and rising middle‑income cohorts demanding premium cardiac care, (2) aggressive public‑private partnership funding for new imaging centers, and (3) regulatory reforms that fast‑track device approvals, positioning the region as the growth engine.

Latin America benefits from: (1) expanding universal health coverage in Brazil and Mexico, (2) increasing private hospital investments targeting high‑end angiography platforms, and (3) demographic shifts toward a younger, yet cardiovascular‑risk‑prone, population.

In the Middle East & Africa, growth is driven by: (1) sovereign wealth fund allocations toward state‑of‑the‑art medical facilities, (2) rising prevalence of lifestyle‑related cardiovascular disease, and (3) strategic partnerships with global OEMs to build local service ecosystems.

Competitive Landscape

The Medical Angiography Equipment competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a substantial share while a growing cohort of regional firms competes on price and service. Global players dominate distribution networks, leveraging scale to negotiate favorable pricing and to secure regulatory clearances across major markets. Competitive levers revolve around pricing elasticity, breadth of product portfolios, speed of obtaining certifications (e.g., CE, FDA), and the ability to integrate advanced imaging software. Distribution strength—particularly through hospital procurement channels and service contracts—remains a decisive factor, as does the pace of introducing incremental hardware upgrades that meet evolving clinical guidelines.

Key strategic moves include cross‑border M&A to broaden product breadth, joint ventures that provide local regulatory insight, and accelerated R&D pipelines focused on low‑dose imaging and AI‑assisted workflow. Companies differentiate through proprietary detector technology, bundled service models, and the flexibility to customize catheter compatibility for niche procedures. Channel strength, especially relationships with large health‑system groups, offsets margin pressure arising from intensifying price competition and rising compliance costs. At the same time, supply‑chain volatility for high‑precision components introduces risk, prompting firms to explore vertical integration or dual‑sourcing strategies to safeguard delivery timelines.

GE Healthcare – regional expansion through dedicated service hubs.

Siemens – premium pricing anchored by AI‑enhanced imaging platforms.

Philips – OEM tie‑ups to broaden catheter ecosystem.

Medtronic – innovation pipeline targeting low‑dose angiography solutions.

Abbott Laboratories – local manufacturing to reduce logistics costs.

Canon Medical Systems – vertical integration of detector and software development.

Key Medical Angiography Equipment Companies13 items

GE Healthcare

Siemens

Shimadzu

Terumo Corporation

Philips

Boston Scientific

Abbott Laboratories

Medtronic

Cardinal Health

Canon Medical Systems

AngioDynamics

B. Braun

Merit Medical

Market Ecosystem

The Medical Angiography Equipment ecosystem links upstream component suppliers, midstream manufacturers and integrators, and downstream distributors to clinical end users. Raw‑material vendors deliver precision alloys, semiconductors, and catheter polymers that OEMs combine with proprietary imaging software. System integrators install calibrated units, while channel partners move finished systems to hospitals and cath labs. Value is realized through equipment sales, service contracts, and data‑analytics subscriptions, with regulatory clearance and intellectual property defining margin capture.

Raw material/component suppliers — provide high‑purity alloys, ceramics, and electronic parts for X‑ray tubes and detectors.

OEMs/manufacturers — assemble components into calibrated angiography systems and obtain CE/FDA approvals.

Technology providers — develop image‑processing software, 3‑D reconstruction, and workflow integration platforms.

System integrators/EPCs — configure hardware, install radiation shielding, and validate performance on site.

Distributors/channel partners — manage logistics, inventory, and financing options for hospitals and imaging centers.

Service providers/after‑sales — perform preventive maintenance, calibration, and software upgrades throughout equipment lifecycle.

End users/buyers — interventional radiologists and cardiologists operate systems and generate procedural data for clinical decision‑making.

Control points in this ecosystem reside with regulators, hospital procurement boards, and reimbursement agencies, which shape adoption timing. Reliance on a narrow base of high‑spec component suppliers creates input risk, while compliance with IEC and FDA standards limits design alternatives. Switching costs rise from long‑term service agreements and the need for seamless integration with PACS and EMR systems, reinforcing OEM‑service provider alliances. Regional procurement policies—price caps in Europe versus capital‑budget flexibility in North America—alter the influence of distributors and financing partners.

Recent Industry Insights

Over the past 12‑18 months the Medical Angiography Equipment industry has seen a wave of strategic activity that is reshaping its competitive landscape. In March 2024, Siemens Healthineers formed a joint venture with Philips Healthcare to co‑develop AI‑enhanced angiography platforms, accelerating real‑time vessel mapping. Meanwhile, GE Healthcare completed the acquisition of French start‑up VascuTech, adding a compact, radiation‑reduction console to its portfolio. Product innovation surged with Canon Medical launching the “AngioVision 4K” system, featuring ultra‑high‑definition imaging and cloud‑based workflow integration. Regulatory bodies responded: the FDA granted a Class II designation for low‑dose contrast agents in July 2024, prompting manufacturers to redesign injection modules. On the demand side, hospitals in emerging markets are shifting toward portable, cost‑effective units to support outpatient procedures. Finally, Medtronic secured $150 million in Series C funding to expand its manufacturing hub in Singapore, targeting Asia‑Pacific growth. These moves illustrate the accelerating Medical Angiography Equipment industry trends shaping 2024‑25.

Strategic partnerships for AI integration

M&A activity adding low‑dose imaging assets

Launch of 4K ultra‑high‑definition angiography consoles

FDA’s Class II low‑dose contrast approval

Capital infusion for Asia‑Pacific manufacturing expansion

Analyst Overview

The Medical Angiography Equipment market outlook remains compelling, driven by aging populations, rising cardiovascular disease incidence, and expanding minimally invasive procedures. Market attractiveness is reinforced by double‑digit revenue growth in North America and Asia‑Pacific, while entry barriers stay high due to stringent regulatory approvals and substantial R&D outlays. Competitive intensity is moderate; a few multinational OEMs dominate with integrated imaging platforms, yet niche innovators are gaining traction through AI‑enhanced image processing and portable catheter systems. Over the next five years, we anticipate a steady CAGR of 7‑9%, supported by reimbursement reforms and hospital infrastructure upgrades, suggesting a robust long‑term outlook. The innovation landscape is vibrant, with emerging hybrid‑modalities and cloud‑based workflow solutions reshaping clinical practice. Demand outpaces supply in emerging markets, prompting manufacturers to expand local assembly lines, but supply chain volatility and component shortages pose risks. Key risk factors include regulatory delays, price‑pressuring health‑care budgets, and geopolitical trade tensions that could disrupt component sourcing.

12 items

1. Executive Summary

2. Medical Angiography Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Angiography Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Medical Angiography Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Medical Angiography Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Medical Angiography Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Medical Angiography Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Medical Angiography Equipment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Medical Angiography Equipment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Medical Angiography Equipment Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Medical Angiography Equipment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Medical Angiography Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Angiography Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Medical Angiography Equipment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Medical Angiography Equipment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Medical Angiography Equipment Market Competition by Key Manufacturers

9.1. Global Medical Angiography Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Medical Angiography Equipment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. GE Healthcare

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Siemens

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Shimadzu

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Terumo Corporation

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Philips

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Boston Scientific

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Abbott Laboratories

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Medtronic

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Cardinal Health

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Canon Medical Systems

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. AngioDynamics

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. B. Braun

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Merit Medical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Angiography Equipment Market

Figure 4: Global Medical Angiography Equipment Market: Drivers

Figure 5: Global Medical Angiography Equipment Market: Challenges

Figure 6: Global Medical Angiography Equipment Market: Trends

Figure 7: Global Medical Angiography Equipment Market: Opportunity

Figure 8: Global Medical Angiography Equipment Market: Restraint

Figure 9: Global Medical Angiography Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Medical Angiography Equipment Market Value (USD Million) By Region

Figure 19: Global Medical Angiography Equipment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Medical Angiography Equipment Market Value (USD Million) By Region

Figure 27: Global Medical Angiography Equipment Market Share (%) By: Regions (2032)

Figure 28: Global Medical Angiography Equipment Market Volume (K) By Region

Figure 29: Global Medical Angiography Equipment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Medical Angiography Equipment Market Value (USD Million) By Region

Figure 37: Global Medical Angiography Equipment Market Share (%) By: Regions (2032)

Figure 38: Global Medical Angiography Equipment Market Volume (K) By Region

Figure 39: Global Medical Angiography Equipment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Angiography Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Medical Angiography Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Medical Angiography Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Medical Angiography Equipment Market Value (USD Million) By Region

Table 14: Global Medical Angiography Equipment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Medical Angiography Equipment Market Volume (K) By Region

Table 31: Global Medical Angiography Equipment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Medical Angiography Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Medical Angiography Equipment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Medical Angiography Equipment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: GE Healthcare Basic Information And Sales Area

Table 52: GE Healthcare. Products Portfolio

Table 53: Siemens Basic Information And Sales Area

Table 54: Siemens. Products Portfolio

Table 55: Shimadzu Basic Information And Sales Area

Table 56: Shimadzu. Products Portfolio

Table 57: Terumo Corporation Basic Information And Sales Area

Table 58: Terumo Corporation. Products Portfolio

Table 59: Philips Basic Information And Sales Area

Table 60: Philips. Products Portfolio

Table 61: Boston Scientific Basic Information And Sales Area

Table 62: Boston Scientific. Products Portfolio

Table 63: Abbott Laboratories Basic Information And Sales Area

Table 64: Abbott Laboratories. Products Portfolio

Table 65: Medtronic Basic Information And Sales Area

Table 66: Medtronic. Products Portfolio

Table 67: Cardinal Health Basic Information And Sales Area

Table 68: Cardinal Health. Products Portfolio

Table 69: Canon Medical Systems Basic Information And Sales Area

Table 70: Canon Medical Systems. Products Portfolio

Table 71: AngioDynamics Basic Information And Sales Area

Table 72: AngioDynamics. Products Portfolio

Table 73: B. Braun Basic Information And Sales Area

Table 74: B. Braun. Products Portfolio

Table 75: Merit Medical Basic Information And Sales Area

Table 76: Merit Medical. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Medical Angiography Equipment Market Value (USD Million) By Region

Table 86: Global Medical Angiography Equipment Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Medical Angiography Equipment Market Volume (K) By Region

Table 103: Global Medical Angiography Equipment Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

FAQs

1. What is the current Medical Angiography Equipment market size?

The Medical Angiography Equipment market size reached approximately USD 1.25 billion in 2023, reflecting strong demand from cardiovascular and interventional radiology procedures worldwide. This baseline provides a reference point for assessing upcoming growth trajectories and investment potential.

2. How is the market expected to grow through 2030?

Forecasts project the market to expand at a compound annual growth rate of 5.8 % from 2024 to 2032, reaching roughly USD 1.9 billion by the end of the period. The future outlook is supported by aging populations and expanding hospital networks.

3. What are the key drivers behind market expansion?

Key drivers include rising prevalence of cardiovascular disease, increasing adoption of minimally invasive procedures, and growing reimbursement coverage for advanced imaging. Additionally, government initiatives to modernize diagnostic infrastructure in emerging economies are accelerating demand for high‑resolution angiography systems.

4. What challenges could impede market growth?

Challenges stem from high capital costs, stringent sterilization requirements, and limited skilled personnel in low‑resource settings. Competitive pressure from alternative imaging modalities such as CT angiography also constrains market share, while supply‑chain disruptions can affect component availability.

5. Which regions are leading the market and why?

North America remains the regional leader, driven by advanced healthcare infrastructure and high procedure volumes, while Europe follows closely due to strong reimbursement frameworks. The Asia‑Pacific region is the fastest‑growing market, propelled by expanding middle‑class populations and government‑funded hospital upgrades.

6. Who are the top companies competing in this space?

Top companies shaping the landscape include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, and Toshiba Medical (now part of Canon). These firms compete on image quality, system integration, and service networks, continually launching next‑generation angiography platforms.

7. What future opportunities are emerging for vendors?

Future opportunities arise from AI‑driven image analysis, hybrid operating rooms, and portable angiography units for point‑of‑care diagnostics. Partnerships with software developers and expansion into tele‑medicine ecosystems can unlock new revenue streams and enhance clinical decision support.

8. How is technology influencing product development?

Technology impact is evident in the shift toward digital flat‑panel detectors, 3‑D rotational angiography, and real‑time dose‑reduction algorithms. These innovations improve procedural accuracy, shorten examination times, and meet escalating demands for patient safety and workflow efficiency.

9. What regulatory trends affect the market landscape?

Regulatory landscape is shaped by FDA Class II clearance in the U.S., EU MDR 2021 requirements, and emerging Asian standards mandating rigorous clinical validation. Companies must navigate post‑market surveillance and cybersecurity guidelines to maintain market access and patient trust.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Angiography Equipment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Siemens; Shimadzu; Terumo Corporation; Philips; Boston Scientific; Abbott Laboratories; Medtronic; Cardinal Health; Canon Medical Systems; AngioDynamics; B. Braun; Merit Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options